Search for a command to run...
Nureca Ltd. is facing significant financial challenges compared to its peers in the Medical Equipment/Supplies/Accessories sector. With negative earnings, low profitability metrics, and overvaluation, it appears to be underperforming. Meanwhile, Poly Medicure Ltd. stands out as a strong competitor with solid profitability and growth metrics, while other peers exhibit varying degrees of financial health and valuation attractiveness.
Stock | CMP | Market Cap | P/E | ROE (%) | ROCE (%) | Debt/Equity |
|---|---|---|---|---|---|---|
| NURECA | ₹255.55 | ₹257.00Cr | 62.58 | -0.92% | -1.06% | 0.00 |
| POLYMED | ₹1,914.60 | ₹19,411.86Cr | 54.28 | 16.01% | 20.37% | 0.06 |
| LAXMIDENTL | ₹325.20 | ₹1,788.19Cr | 56.28 | 21.40% | 24.96% | 0.06 |
| OSELDEVICE | ₹677.30 | - | 0.00 | - | - | - |
| Prevest Denpro Ltd. | ₹520.00 | ₹624.16Cr | 33.05 | 18.70% | 25.24% | - |
| Hemant Surgical Industries Ltd. | ₹289.00 | ₹376.81Cr | 46.86 | 12.73% | 13.58% | 0.49 |
| YASHOPTICS | ₹133.00 | - | 0.00 | - | - | - |